from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2517c/-

LFCtreatmentdescriptionclass of inhibitor

1.780

Amikacinug/mL Amikacintranslation

1.251

Cap5-10ug/mL Capreomycintranslation

2.061

Rox10-50 ug/mL Roxithromycintranslation

1.397

SM2-5 ug/mL Streptomycintranslation

1.607

Tet5-10 ug/mL Tetracyclinetranslation

-0.544

Rif0.2-5ug/mL Rifampicintranscription

-0.582

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.126

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.514

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.412

CPZ10-50 ug/mL Chlorpromazinerespiration

0.258

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.281

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.768

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.597

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.005

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.201

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.059

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.104

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.013

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.052

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.580

KCN5-20 ug/mL Potassium cyaniderespiration

-0.788

NaN30.2-2 mM Sodium aziderespiration

-0.146

Nigericin50 uM Nigericinrespiration

0.458

TRC10-150 ug/mL Triclosanrespiration

0.828

TRZ10-25 ug/mL Thioridazinerespiration

1.701

Valinomycin0.5-10 uM Valinomycinrespiration

-1.165

ZnSO42 mM ZnSO4respiration

0.050

menadione6-10 ug/mL Menadionerespiration

-0.269

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.540

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.431

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.353

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.052

NRP_1Non-replicating persistence stage 1dosRassociated

-0.371

Amp0.2mg/mL AmpicillincellWall

-0.609

Cephalexin20-100 ug/mL CephalexincellWall

-0.330

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.484

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.484

EMB10-20 ug/mL EthambutolcellWall

-0.245

Eta12-40 ug/mL EthionamidecellWall

-0.120

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.332

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.035

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.332

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.237

BZA0.12 mg/mL BenzamidearomaticAmides

0.209

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.489

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.918

H2O24 mM hydrogen peroxideDNAdamaging

-0.490

Levo10 ug/mL LevofloxacinDNAdamaging

-1.057

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.257

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.511

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.173

UVUV-irradiationDNAdamaging

0.435

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.881

Antimycin12.5-50 ug/mL Antimycin A?

-0.371

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.868

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.049

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.150

PA8240.2-2 ug/mL PA-824?

0.635

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.377

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.232

Verapamil50 uM Verapamil?

-0.471

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.331

methoxatin10-20 ug/mL Methoxatin?